Nonetheless, TLR3/RLR inhibitor CYT387 indeed enhanced bat organoid infection of SARS-CoV-2 and CoV-HKU4 more prominently than the human counterparts at the early phase of infections (Fig. 5). Here, DHX58 is linked to infection.